Related Experiment Video
Updated: Oct 11, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Takotsubo cardiomyopathy associated with dydrogesterone use
1Royal Free London NHS Foundation Trust, London, UK adamioannou14@gmail.com.
Takotsubo cardiomyopathy, a stress-induced heart condition, is typically seen in postmenopausal women. This report details the first case in a premenopausal woman linked to dydrogesterone use.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Takotsubo cardiomyopathy (TTC) is characterized by transient left ventricular apical ballooning without coronary artery disease, often triggered by emotional or physical stress.
- The condition predominantly affects postmenopausal women, leading to speculation about the role of female sex hormones in its pathogenesis.
Observation:
- This case report presents a premenopausal woman who developed Takotsubo cardiomyopathy.
- The onset of symptoms coincided with the initiation of dydrogesterone, a synthetic progestin.
Findings:
- This is the first reported instance of Takotsubo cardiomyopathy associated with dydrogesterone therapy.
- The case challenges the established link between TTC and postmenopausal status, suggesting other hormonal factors may be involved.
Implications:
- The findings suggest that synthetic progestins like dydrogesterone could potentially trigger Takotsubo cardiomyopathy, even in premenopausal women.
- Further research is warranted to explore the role of specific hormonal profiles and synthetic progestins in the development of stress-induced cardiomyopathy.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations